Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary--a new therapeutic approach?
Main Authors: | Malik, S. T., Slevin, M. L. |
---|---|
Format: | Online |
Language: | English |
Published: |
1991
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971854/ |
Similar Items
-
A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.
by: Downer, S., et al.
Published: (1993) -
An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer.
by: Johnson, J. R., et al.
Published: (1984) -
Effects of medroxyprogesterone acetate (MPA) in activating progesterone receptor signaling in benign and cancer-associated fibroblasts of the endometrium
by: Chung, I., et al.
Published: (2017) -
Progestagens for granulosa cell tumours of the ovary.
by: Isaacs, R., et al.
Published: (1992) -
Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial☆☆☆
by: Nanda, Kavita, et al.
Published: (2016)